Receptor map uncovers hidden sites that could guide asthma drug design
Researchers at the Center for Genomic Regulation (CRG) have developed a new way of identifying new druggable sites on a family of proteins that could help design treatments with fewer side effects for a very wide range of conditions from heart disease to depression.
Read original article on Medical Xpress - latest medical and health news stories →Related news
-
Scientists identify protein driving age-related organ damage
United Kingdom
-
College student mental health improves, but significant needs remain
United Kingdom
-
Biologic drug offers promising protection against alpha-gal syndrome
United Kingdom
-
Stocking epinephrine in schools protects students and eases family financial burdens
United Kingdom
-
Language barriers delay early peanut introduction for many infants
United Kingdom
-
Study reveals frequent insurance denials for pediatric biologic allergy treatments
United Kingdom
-
Biologic drug for eosinophilic esophagitis lowers childhood asthma risk
United Kingdom
-
Blood thinner could offer a new way to treat osteoarthritis
United Kingdom